Share class: HBM Healthcare Investments AG

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,960,000 5,609,912 ( 80.6 %) 188,220 ( 2.704 %) 80.6 %

Major shareholders: HBM Healthcare Investments AG

NameEquities%Valuation
Nogra Group SICAF-SIF SA
16.4 %
1,105,207 16.4 % 278 M CHF
HBM Healthcare Investments AG
3.1 %
208,941 3.1 % 53 M CHF
Saba Capital Management LP
2.961 %
199,573 2.961 % 50 M CHF
Carnegie Fonder AB
1.395 %
94,023 1.395 % 24 M CHF
0.6633 %
44,707 0.6633 % 11 M CHF
PMG Investment Solutions AG
0.5104 %
34,400 0.5104 % 9 M CHF
Partners Group Inc (United States)
0.4905 %
33,059 0.4905 % 8 M CHF
Entrepreneur Partners AG
0.4323 %
29,135 0.4323 % 7 M CHF
LUKB Expert Fondsleitung AG
0.3417 %
23,031 0.3417 % 6 M CHF
Axxion SA (Luxembourg)
0.2232 %
15,041 0.2232 % 4 M CHF
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Other19.5%
Institutional7.36%
Individuals0.97%
Unknown72.17%

Based on 1000 largest holdings

Geographical origin of shareholders

Luxembourg
16.63%
Switzerland
4.58%
United States
3.45%
Sweden
1.57%
Individuals
0.97%
Liechtenstein
0.21%
United Kingdom
0.16%
Finland
0.12%
Germany
0.12%
Spain
0.03%

Based on 1000 largest holdings

Logo HBM Healthcare Investments AG
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Employees
700
More about the company